Target intelligence / Profile preview

West Nile virus structural proteins (E protein (for envelope), C protein (for capsid); no unified abbreviation for both)

Target
E protein (for envelope), C protein (for capsid); no unified abbreviation for both
Molecular classification
Viral structural protein, Envelope glycoprotein, Capsid protein
01

Overview

West Nile virus structural proteins include the envelope glycoprotein (E) and the capsid protein (C), which are essential for the assembly and infectivity of flaviviruses. The E protein is a class II fusion protein, undergoing conformational rearrangement to mediate virus-cell membrane fusion and viral entry; its structure features three domains and specialized pockets critical for these functions. The C protein forms α-helical homodimers, organizing the nucleocapsid and facilitating viral RNA packaging and assembly. Both proteins share conserved features with other flaviviruses but differ in key residues affecting host specificity and pathogenesis. Disruption of E or C protein function is a promising approach for antiviral drug and vaccine development. If you require structured metadata for a specific protein (E or C), it is recommended to refer to "West Nile virus envelope glycoprotein" or "West Nile virus capsid protein" rather than the ambiguous “structural proteins.”

Other names
West Nile virus E proteinWest Nile virus capsid proteinWNV envelope proteinWNV C protein
02

Mechanism of action

Inhibitors may block membrane fusion by binding the E protein’s hydrophobic pocket or prevent capsid assembly; Vaccines elicit neutralizing antibodies targeting E protein epitopes

03

Biological functions

Viral entry (E protein mediates membrane fusion and attachment)Viral assembly (C protein forms nucleocapsid)Immune evasion (glycosylation and antigenic variation)
04

Disease associations

Infection (West Nile fever, neuroinvasive disease)Other (viral pathogenesis)
05

Safety considerations

Potential for cross-reactivity with other flavivirus proteins (e.g., Dengue, Zika), leading to antibody-dependent enhancement or immune complicationsChallenges in targeting viral structural proteins without affecting host cell functions
06

Interacting drugs

No approved direct-acting antivirals; ongoing research targets include entry/fusion inhibitors and capsid assembly disruptors
07

Biomarkers

Anti-envelope protein (E) antibodies (diagnosis, vaccine efficacy)Viral RNA (general marker, not specific to structural proteins)

Beyond the preview

Go deeper on West Nile virus structural proteins (E protein (for envelope), C protein (for capsid); no unified abbreviation for both).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on West Nile virus structural proteins (E protein (for envelope), C protein (for capsid); no unified abbreviation for both).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call